<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04142658</url>
  </required_header>
  <id_info>
    <org_study_id>ONX1801.000-C</org_study_id>
    <nct_id>NCT04142658</nct_id>
  </id_info>
  <brief_title>PROACT Xa - A Trial to Determine if Participants With an On-X Aortic Valve Can be Maintained Safely on Apixaban</brief_title>
  <official_title>A Prospective, Randomized, Active (Warfarin) Controlled, Parallel-arm Clinical Trial to Determine if Participants With an On-X Aortic Valve Can be Maintained Safely and Effectively on Apixaban</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CryoLife, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Duke Clinical Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>CryoLife, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Currently, warfarin is the only approved anticoagulation for patients with mechanical valves.&#xD;
      The purpose of this study is to determine if participants with an On-X Prosthetic Heart Valve&#xD;
      / On-X aortic valve can be maintained safely and effectively on apixaban. Both the On-X&#xD;
      aortic valve and apixaban have been approved for use by the US Food and Drug Administration&#xD;
      (FDA) but they have not been approved to be used together.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      There is an unmet clinical need for an alternative to warfarin, such as a direct oral&#xD;
      anticoagulant (DOAC), as anticoagulation in participants with an aortic mechanical prosthetic&#xD;
      valve. Some participants may be genetically hyper- or hypo-responsive to warfarin, which&#xD;
      makes management difficult. Another small group of participants is allergic to warfarin. A&#xD;
      much larger group of participants has difficulty maintaining warfarin control due to dietary&#xD;
      and drug interactions. Finally, the requirement for routine blood testing makes people&#xD;
      reluctant to take warfarin. All of these factors drive younger participants in need of aortic&#xD;
      valve replacement (AVR) toward selection of a tissue valve instead of a mechanical valve.&#xD;
      Despite multiple studies (randomized, matched and risk adjusted) that show that tissue valves&#xD;
      are associated with worse outcomes, younger participants choose this type of valve to avoid&#xD;
      warfarin. In addition, multiple clinical studies have shown valve reoperation rates are&#xD;
      higher for tissue valves used in these younger participants. Providing an alternative to&#xD;
      warfarin anticoagulation may lead younger participants to choose a mechanical valve with&#xD;
      greater durability and better clinical outcomes.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2020</start_date>
  <completion_date type="Anticipated">July 2024</completion_date>
  <primary_completion_date type="Anticipated">June 2022</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Parallel control and treatment arm at a 1:1 ratio.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Co-Primary Efficacy Objective</measure>
    <time_frame>2 years</time_frame>
    <description>To determine if apixaban is non-inferior to warfarin (INR target range 2.0 - 3.0) for patients with an On-X mechanical heart valve implanted in the aortic position for the primary composite outcome of valve thrombosis and valve-related thromboembolism.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Co-Primary Efficacy Objective</measure>
    <time_frame>2 years</time_frame>
    <description>To determine if apixaban provides acceptable anticoagulation for patients with an On-X mechanical heart valve implanted in the aortic position for the primary composite outcome of valve thrombosis and valve-related thromboembolism compared with an objective performance criterion.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of major bleeding events (superiority)</measure>
    <time_frame>2 years</time_frame>
    <description>To determine if apixaban is superior to warfarin (INR target range 2.0 - 3.0) in the safety outcome of major bleeding in patients with an On-X mechanical heart valve implanted in the aortic position.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of valve-related thrombotic events (superiority)</measure>
    <time_frame>2 years</time_frame>
    <description>To determine if apixaban is superior to warfarin (INR target range 2.0 - 3.0) for the primary composite outcome of valve thrombosis and valve-related thromboembolism in patients with an On-X mechanical heart valve implanted in the aortic position.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Secondary Efficacy Objective</measure>
    <time_frame>2 years</time_frame>
    <description>To compare apixaban with warfarin (INR target range 2.0 - 3.0) for the individual components of the primary outcome (valve thrombosis and valve-related thromboembolism) in patients with an On-X mechanical heart valve implanted in the aortic position.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Secondary Efficacy Objective</measure>
    <time_frame>2 years</time_frame>
    <description>To compare apixaban with warfarin (INR target range 2.0 - 3.0) for the primary composite outcome of valve thrombosis and valve-related thromboembolism in prespecified subgroups of patients with an On-X mechanical heart valve implanted in the aortic position.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Aortic Valve Disease</condition>
  <condition>Aortic Valve Stenosis</condition>
  <condition>Aortic Valve Failure</condition>
  <arm_group>
    <arm_group_label>Apixaban</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Apixaban 5 mg twice daily(BID) or 2.5 mg BID</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Warfarin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients randomized to the warfarin arm will continue warfarin in the INR range of (2.0-3.0)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Apixaban 5 MG</intervention_name>
    <description>For patients that do NOT meet the following criteria&#xD;
age ≥ 80 years&#xD;
weight ≤ 60 kilograms&#xD;
creatinine ≥ 1.5 mg/dL (133 micromol/L)</description>
    <arm_group_label>Apixaban</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Apixaban 2.5 MG</intervention_name>
    <description>For patients that meet at least 2 of the following criteria&#xD;
age ≥ 80 years&#xD;
weight ≤ 60 kilograms&#xD;
creatinine ≥ 1.5 mg/dL (133 micromol/L)</description>
    <arm_group_label>Apixaban</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Warfarin</intervention_name>
    <description>Active Control Intervention</description>
    <arm_group_label>Warfarin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>On-X Aortic Mechanical Valve</intervention_name>
    <description>Inclusion Criterion: Implantation of an On-X mechanical valve in the aortic position at least 3 months (90 days) ago.</description>
    <arm_group_label>Apixaban</arm_group_label>
    <arm_group_label>Warfarin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male or female at least 18 years of age at the time of giving informed consent.&#xD;
&#xD;
          -  Participants currently receiving warfarin anticoagulation and who are able to receive&#xD;
             warfarin with a target INR 2.0 to 3.0.&#xD;
&#xD;
          -  Participants are able to take low-dose aspirin at a dose of 75 -100 mg daily or have a&#xD;
             documented contraindication to aspirin use.&#xD;
&#xD;
          -  Implantation of an On-X mechanical valve in the aortic position at least 3 months (90&#xD;
             days) ago.&#xD;
&#xD;
          -  Female participants of childbearing potential, including those who are less than 2&#xD;
             years post-menopausal, must agree to, and comply with using a highly effective method&#xD;
             of birth control (eg, barrier contraceptives [condom or diaphragm with a spermicidal&#xD;
             gel], hormonal contraceptives [implants, injectables, combination oral contraceptives,&#xD;
             transdermal patches, or contraceptive rings], intrauterine devices or sexual&#xD;
             abstinence) while partaking in this study. In addition, all women of childbearing&#xD;
             potential must agree to continue to use birth control throughout the study until last&#xD;
             study visit.&#xD;
&#xD;
          -  Informed of the full nature and purpose of the study, including possible risks and&#xD;
             side effects, given ample time and opportunity to read and understand this&#xD;
             information, and sign and date the written informed consent before inclusion in the&#xD;
             study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Mechanical valve in any position other than aortic valve.&#xD;
&#xD;
          -  Any cardiac surgery in the three months (90 days) prior to enrollment.&#xD;
&#xD;
          -  Need to be on aspirin &gt;100 mg daily or a P2Y12 inhibitor (clopidogrel, ticagrelor,&#xD;
             prasugrel, or ticlopidine).&#xD;
&#xD;
          -  Known hypersensitivity or other contraindication to apixaban.&#xD;
&#xD;
          -  On dialysis or a creatinine clearance &lt; 25 mL/min.&#xD;
&#xD;
          -  Ischemic stroke or intracranial hemorrhage within 3 months.&#xD;
&#xD;
          -  Active pathological bleeding at the time of screening for enrollment.&#xD;
&#xD;
          -  Active endocarditis at the time of screening for enrollment.&#xD;
&#xD;
          -  Pregnant, plan to become pregnant, or are breast feeding.&#xD;
&#xD;
          -  On concomitant combined strong P-gp and CYP3A4 inducers or inhibitors.&#xD;
&#xD;
          -  History of non-compliance with recommended monthly INR testing.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lars Svensson, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Steering Committee</affiliation>
  </overall_official>
  <overall_official>
    <last_name>John Alexander, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Steering Committee</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Brittanny Boyer, BS</last_name>
    <phone>1-888-427-9654</phone>
    <email>proactxainfo@cryolife.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Amy Mahoney, BS</last_name>
    <email>proactxainfo@cryolife.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Tucson Heart Center</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85712</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tiphanie Worthington</last_name>
      <phone>520-838-2115</phone>
      <phone_ext>72183</phone_ext>
      <email>TiphanieW@pimaheart.com</email>
    </contact>
    <investigator>
      <last_name>Raj Bose, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHI St. Vincent Heart Institute</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lynn Bass</last_name>
      <email>lbass@stvincenthealth.com</email>
    </contact>
    <investigator>
      <last_name>Thomas S Rayburn, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Loma Linda University Medical Center</name>
      <address>
        <city>Loma Linda</city>
        <state>California</state>
        <zip>92354</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kimberly Gilfillan</last_name>
      <email>KGilfillan@llu.edu</email>
    </contact>
    <investigator>
      <last_name>Anees J Razzouk, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stanford University Medical Center</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tiffany Koyano</last_name>
      <email>tkoyano3@stanford.edu</email>
    </contact>
    <investigator>
      <last_name>Michael Fischbein, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sharp Memorial</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92123</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Donna Small</last_name>
      <email>dsmall@sdcardiac.com</email>
    </contact>
    <investigator>
      <last_name>Karl Limmer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hartford Hospital</name>
      <address>
        <city>Hartford</city>
        <state>Connecticut</state>
        <zip>06102</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cindy Marques</last_name>
      <email>cynthia.marques@hhchealth.org</email>
    </contact>
    <investigator>
      <last_name>Robert C Hagberg</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Yale- New Haven Hospital</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06510</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maryann Babcock</last_name>
      <email>maryann.babcock@yale.edu</email>
    </contact>
    <investigator>
      <last_name>John A. Elefteriades, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shands Hospital (University of Florida Health)</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32608</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessica Cobb, PhD, CCRP</last_name>
      <email>jessica.cobb@surgery.ufl.edu</email>
    </contact>
    <investigator>
      <last_name>Thomas Beaver, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AdventHealth Orlando</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32803</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Millie Lopez</last_name>
      <email>Millie.Lopez@AdventHealth.com</email>
    </contact>
    <investigator>
      <last_name>Kevin D Accola, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tallahassee Memorial Hospital</name>
      <address>
        <city>Tallahassee</city>
        <state>Florida</state>
        <zip>32308</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rebecca Plasay</last_name>
      <email>rebecca.plasay@tmh.org</email>
    </contact>
    <investigator>
      <last_name>David Saint, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of South Florida</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thanh Tran</last_name>
      <email>thanhtran@health.usf.edu</email>
    </contact>
    <investigator>
      <last_name>Erol Belli, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Indian River</name>
      <address>
        <city>Vero Beach</city>
        <state>Florida</state>
        <zip>32960</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Piedmont Atlanta Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30309</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gigi Davis</last_name>
      <email>gigi.davis@piedmont.org</email>
    </contact>
    <investigator>
      <last_name>Vinod Thourani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Emory University Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30332</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sonya Mathewson</last_name>
      <phone>678-843-6092</phone>
      <email>sbmathe@emory.edu</email>
    </contact>
    <investigator>
      <last_name>Bradley Leshnower, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northeast Georgia Medical Center</name>
      <address>
        <city>Gainesville</city>
        <state>Georgia</state>
        <zip>30501</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Donna Patrick</last_name>
      <email>donna.patrick@nghs.com</email>
    </contact>
    <investigator>
      <last_name>Alan Wolfe, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northwestern Memorial</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Warzecha</last_name>
      <phone>312-926-0846</phone>
      <email>anna.warzecha@nm.org</email>
    </contact>
    <investigator>
      <last_name>Chris Malaisrie, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>OSF Cardiovascular Institute</name>
      <address>
        <city>Rockford</city>
        <state>Illinois</state>
        <zip>61107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Barbara Connors</last_name>
      <phone>815-395-9181</phone>
      <email>barbara.l.connors@osfhealthcare.org</email>
    </contact>
    <investigator>
      <last_name>David G Cable, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Indiana University Health Methodist Hospital</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Terri Strickland</last_name>
      <email>tstrickland@iuhealth.org</email>
    </contact>
    <investigator>
      <last_name>Joel S Corvera, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Franciscan/ St. Francis</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46237</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tadd Behner</last_name>
      <email>tadd.behner@franciscanalliance.org</email>
    </contact>
    <investigator>
      <last_name>Vijay Rao, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Iowa</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jaclyn Searls</last_name>
      <phone>319-353-8204</phone>
      <email>jackie-searls@uiowa.edu</email>
    </contact>
    <investigator>
      <last_name>Sharon Larson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Maine Medical Center</name>
      <address>
        <city>Portland</city>
        <state>Maine</state>
        <zip>04102</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Betsey Gallant</last_name>
      <email>Bgallant@mmc.org</email>
    </contact>
    <investigator>
      <last_name>Reed Quinn, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>John's Hopkins University</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21218</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kate Calligy</last_name>
      <email>kcummi15@jhmi.edu</email>
    </contact>
    <investigator>
      <last_name>Jennifer Lawton, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Brigham and Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mariam Beshoy Kerolos</last_name>
      <email>mkerolos@bwh.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>Ashraf Sabe, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Debbie Conboy, RN, BSN</last_name>
      <email>dconboy@bidmc.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>David Liu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Abbott Northwestern Hospital</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55407</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Tindell</last_name>
      <email>lisa.tindell@allina.com</email>
    </contact>
    <investigator>
      <last_name>Benjamin Sun, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Minnesota</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55422</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Surgery Clinical Trials Office</last_name>
      <phone>612-624-7463</phone>
      <email>SurgCTO@umn.edu</email>
    </contact>
    <investigator>
      <last_name>Andrew Shaffer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic Rochester</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55902</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Timmons</last_name>
      <email>timmons.mary@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>Alberto Pochettino, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Saint Luke's Hospital</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64111</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diane Peterman</last_name>
      <phone>816-932-5989</phone>
      <email>dpeterman@saint-lukes.org</email>
    </contact>
    <investigator>
      <last_name>John R Davis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Washington University Medical Center</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catherine Cooper</last_name>
      <email>catherine.cooper@wustl.edu</email>
    </contact>
    <investigator>
      <last_name>Marc Moon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Missouri Baptist Medical Center</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63131</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc Haynes, BSN</last_name>
      <phone>314-996-5708</phone>
      <email>mph7052@bjc.org</email>
    </contact>
    <investigator>
      <last_name>James Scharff, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Nebraska Medical Center</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68198</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Hays, RN</last_name>
      <email>sarah.hays@unmc.edu</email>
    </contact>
    <investigator>
      <last_name>Aleem Siddique, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mount Sinai- St. Luke's Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>John Puskas, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NewYork-Presbyterian Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michelle Yuan</last_name>
      <email>my2573@cumc.columbia.edu</email>
    </contact>
    <investigator>
      <last_name>Hiroo Takayama, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NewYork-Presbyterian/ Weill Cornell Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nathan Palaparthi</last_name>
      <email>ntp2001@med.cornell.edu</email>
    </contact>
    <investigator>
      <last_name>Christopher Lau, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vassar Brothers Medical Center</name>
      <address>
        <city>Poughkeepsie</city>
        <state>New York</state>
        <zip>12601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tricia Landi</last_name>
    </contact>
    <investigator>
      <last_name>Jason Sperling, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Rochester Medical Center</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14642</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lori Caufield</last_name>
      <email>lori_caufield@urmc.rochester.edu</email>
    </contact>
    <investigator>
      <last_name>Peter Knight, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Atrium Health Carolinas Medical Center (CMC)</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>John R. Frederick, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Duke University</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27708</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan Hajmohammad</last_name>
      <email>susan.hajmohammad@duke.edu</email>
    </contact>
    <investigator>
      <last_name>Chad Hughes, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Alice Bowman</last_name>
      <email>bowmanm3@ccf.org</email>
    </contact>
    <investigator>
      <last_name>Douglas Johnston, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ProMedica Toledo Hospital</name>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <zip>43606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lani Brighton</last_name>
      <email>lani.brighton@promedica.org</email>
    </contact>
    <investigator>
      <last_name>Michael Moront, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oklahoma Heart Hospital</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73120</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valerie Gudell</last_name>
      <email>vgudell@okheart.com</email>
    </contact>
    <investigator>
      <last_name>Mohammad K Ghani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lehigh Valley Hospital Allentown</name>
      <address>
        <city>Allentown</city>
        <state>Pennsylvania</state>
        <zip>18103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Eames</last_name>
      <phone>610-402-7195</phone>
      <email>thomas.eames@lvhn.org</email>
    </contact>
    <investigator>
      <last_name>James Wu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Penn State Health Milton S. Hershey Medical Center</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Balakrishnan Mahesh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital of the University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Walsh, RN</last_name>
      <email>Lisa.Walsh@pennmedicine.upenn.edu</email>
    </contact>
    <investigator>
      <last_name>Nimesh Desai, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UPMC Shadyside</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristin Konopka</last_name>
      <email>valcharka@upmc.edu</email>
    </contact>
    <investigator>
      <last_name>Ibrahim Sultan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tristar Centennial Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Molly Harper</last_name>
      <email>molly.harper@hcahealthcare.com</email>
    </contact>
    <investigator>
      <last_name>Seenu Reddy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>William P. Clements Jr. University Hospital</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75235</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tyshay Watson</last_name>
      <email>proactxa@utsouthwestern.edu</email>
    </contact>
    <investigator>
      <last_name>Michael A Wait, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The University of Texas Health Science Center at Houston</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Madiha Hassan, MD, MHS</last_name>
      <phone>713-486-5164</phone>
      <email>madiha.hassan@uth.tmc.edu</email>
    </contact>
    <investigator>
      <last_name>Juan Abreu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Heart Hospital at Baylor Plano</name>
      <address>
        <city>Plano</city>
        <state>Texas</state>
        <zip>75093</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aaron Mercado</last_name>
      <email>aaron.mercadoreza@bswhealth.org</email>
    </contact>
    <investigator>
      <last_name>Katherine Harrington, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Utah Hospital</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84132</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alyssa Messina</last_name>
      <email>alyssa.messina@hsc.utah.edu</email>
    </contact>
    <investigator>
      <last_name>Craig Selzman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Henrico Doctors' Hospital</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Raymond</last_name>
      <email>jennifer.raymond@sarahcannon.com</email>
    </contact>
    <investigator>
      <last_name>Chiwon Hahn, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Carilion Roanoke Memorial Hospital</name>
      <address>
        <city>Roanoke</city>
        <state>Virginia</state>
        <zip>24014</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Ambili</last_name>
      <email>asjohn@carilionclinic.org</email>
    </contact>
    <investigator>
      <last_name>Mark Joseph, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Swedish Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98122</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizabeth Vogt</last_name>
      <email>elizabeth.vogt@swedish.org</email>
    </contact>
    <investigator>
      <last_name>Eric Lehr, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Washington Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carly Mondoy-Loxton</last_name>
      <email>carlyml@uw.edu</email>
    </contact>
    <investigator>
      <last_name>Gabriel S Aldea, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tacoma General Hospital</name>
      <address>
        <city>Tacoma</city>
        <state>Washington</state>
        <zip>98405</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Janey Barnhart, RN</last_name>
      <email>mbarnhart@multicare.org</email>
    </contact>
    <investigator>
      <last_name>Allen H Graeve, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Wisconsin</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53792</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lekha Nelavelli</last_name>
      <phone>608-262-9383</phone>
      <email>nelavelli@surgery.wisc.edu</email>
    </contact>
    <investigator>
      <last_name>Andreas Robert De Biasi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical College of Wisconsin</name>
      <address>
        <city>Wauwatosa</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kelly Potzner</last_name>
      <email>kpotzner@mcw.edu</email>
    </contact>
    <investigator>
      <last_name>Paul Pearson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Canada</country>
  </removed_countries>
  <reference>
    <citation>Akins CW, Miller DC, Turina MI, Kouchoukos NT, Blackstone EH, Grunkemeier GL, Takkenberg JJ, David TE, Butchart EG, Adams DH, Shahian DM, Hagl S, Mayer JE, Lytle BW; Councils of the American Association for Thoracic Surgery; Society of Thoracic Surgeons; European Assoication for Cardio-Thoracic Surgery; Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity. Guidelines for reporting mortality and morbidity after cardiac valve interventions. J Thorac Cardiovasc Surg. 2008 Apr;135(4):732-8. doi: 10.1016/j.jtcvs.2007.12.002.</citation>
    <PMID>18374749</PMID>
  </reference>
  <reference>
    <citation>Bourguignon T, Lhommet P, El Khoury R, Candolfi P, Loardi C, Mirza A, Boulanger-Lothion J, Bouquiaux-Stablo-Duncan AL, Marchand M, Aupart M. Very long-term outcomes of the Carpentier-Edwards Perimount aortic valve in patients aged 50-65 years. Eur J Cardiothorac Surg. 2016 May;49(5):1462-8. doi: 10.1093/ejcts/ezv384. Epub 2015 Nov 2.</citation>
    <PMID>26530269</PMID>
  </reference>
  <reference>
    <citation>Chambers JB, Pomar JL, Mestres CA, Palatianos GM. Clinical event rates with the On-X bileaflet mechanical heart valve: a multicenter experience with follow-up to 12 years. J Thorac Cardiovasc Surg. 2013 Feb;145(2):420-4. doi: 10.1016/j.jtcvs.2011.12.059. Epub 2012 Feb 17.</citation>
    <PMID>22341654</PMID>
  </reference>
  <reference>
    <citation>Eikelboom JW, Connolly SJ, Brueckmann M, Granger CB, Kappetein AP, Mack MJ, Blatchford J, Devenny K, Friedman J, Guiver K, Harper R, Khder Y, Lobmeyer MT, Maas H, Voigt JU, Simoons ML, Van de Werf F; RE-ALIGN Investigators. Dabigatran versus warfarin in patients with mechanical heart valves. N Engl J Med. 2013 Sep 26;369(13):1206-14. doi: 10.1056/NEJMoa1300615. Epub 2013 Aug 31.</citation>
    <PMID>23991661</PMID>
  </reference>
  <reference>
    <citation>Glaser N, Jackson V, Holzmann MJ, Franco-Cereceda A, Sartipy U. Aortic valve replacement with mechanical vs. biological prostheses in patients aged 50-69 years. Eur Heart J. 2016 Sep 7;37(34):2658-67. doi: 10.1093/eurheartj/ehv580. Epub 2015 Nov 11.</citation>
    <PMID>26559386</PMID>
  </reference>
  <reference>
    <citation>Goldstone AB, Chiu P, Baiocchi M, Lingala B, Patrick WL, Fischbein MP, Woo YJ. Mechanical or Biologic Prostheses for Aortic-Valve and Mitral-Valve Replacement. N Engl J Med. 2017 Nov 9;377(19):1847-1857. doi: 10.1056/NEJMoa1613792.</citation>
    <PMID>29117490</PMID>
  </reference>
  <reference>
    <citation>Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, Bahit MC, Diaz R, Easton JD, Ezekowitz JA, Flaker G, Garcia D, Geraldes M, Gersh BJ, Golitsyn S, Goto S, Hermosillo AG, Hohnloser SH, Horowitz J, Mohan P, Jansky P, Lewis BS, Lopez-Sendon JL, Pais P, Parkhomenko A, Verheugt FW, Zhu J, Wallentin L; ARISTOTLE Committees and Investigators. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011 Sep 15;365(11):981-92. doi: 10.1056/NEJMoa1107039. Epub 2011 Aug 27.</citation>
    <PMID>21870978</PMID>
  </reference>
  <reference>
    <citation>Head SJ, Mylotte D, Mack MJ, Piazza N, van Mieghem NM, Leon MB, Kappetein AP, Holmes DR Jr. Considerations and Recommendations for the Introduction of Objective Performance Criteria for Transcatheter Aortic Heart Valve Device Approval. Circulation. 2016 May 24;133(21):2086-93. doi: 10.1161/CIRCULATIONAHA.115.020493. Review.</citation>
    <PMID>27217434</PMID>
  </reference>
  <reference>
    <citation>Head SJ, Çelik M, Kappetein AP. Mechanical versus bioprosthetic aortic valve replacement. Eur Heart J. 2017 Jul 21;38(28):2183-2191. doi: 10.1093/eurheartj/ehx141. Review.</citation>
    <PMID>28444168</PMID>
  </reference>
  <reference>
    <citation>IntHout J, Ioannidis JP, Borm GF. The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method. BMC Med Res Methodol. 2014 Feb 18;14:25. doi: 10.1186/1471-2288-14-25.</citation>
    <PMID>24548571</PMID>
  </reference>
  <reference>
    <citation>Samsa G, Matchar DB, Dolor RJ, Wiklund I, Hedner E, Wygant G, Hauch O, Marple CB, Edwards R. A new instrument for measuring anticoagulation-related quality of life: development and preliminary validation. Health Qual Life Outcomes. 2004 May 6;2:22.</citation>
    <PMID>15132746</PMID>
  </reference>
  <reference>
    <citation>Lester PA, Coleman DM, Diaz JA, Jackson TO, Hawley AE, Mathues AR, Grant BT, Knabb RM, Ramacciotti E, Frost CE, Song Y, Wakefield TW, Myers DD Jr. Apixaban Versus Warfarin for Mechanical Heart Valve Thromboprophylaxis in a Swine Aortic Heterotopic Valve Model. Arterioscler Thromb Vasc Biol. 2017 May;37(5):942-948. doi: 10.1161/ATVBAHA.116.308649. Epub 2017 Feb 23.</citation>
    <PMID>28232327</PMID>
  </reference>
  <reference>
    <citation>McNicholas KW, Ivey TD, Metras J, Szentpetery S, Marra SW, Masters RG, Dilling EW, Slaughter MS, Mack MJ. North American multicenter experience with the On-X prosthetic heart valve. J Heart Valve Dis. 2006 Jan;15(1):73-8; discussion 79.</citation>
    <PMID>16480015</PMID>
  </reference>
  <reference>
    <citation>Palatianos GM, Laczkovics AM, Simon P, Pomar JL, Birnbaum DE, Greve HH, Haverich A. Multicentered European study on safety and effectiveness of the On-X prosthetic heart valve: intermediate follow-up. Ann Thorac Surg. 2007 Jan;83(1):40-6.</citation>
    <PMID>17184628</PMID>
  </reference>
  <reference>
    <citation>Puskas J, Gerdisch M, Nichols D, Quinn R, Anderson C, Rhenman B, Fermin L, McGrath M, Kong B, Hughes C, Sethi G, Wait M, Martin T, Graeve A; PROACT Investigators. Reduced anticoagulation after mechanical aortic valve replacement: interim results from the prospective randomized on-X valve anticoagulation clinical trial randomized Food and Drug Administration investigational device exemption trial. J Thorac Cardiovasc Surg. 2014 Apr;147(4):1202-1210; discussion 1210-1. doi: 10.1016/j.jtcvs.2014.01.004. Epub 2014 Jan 12.</citation>
    <PMID>24512654</PMID>
  </reference>
  <reference>
    <citation>Puskas JD, Gerdisch M, Nichols D, Fermin L, Rhenman B, Kapoor D, Copeland J, Quinn R, Hughes GC, Azar H, McGrath M, Wait M, Kong B, Martin T, Douville EC, Meyer S, Ye J, Jamieson WRE, Landvater L, Hagberg R, Trotter T, Armitage J, Askew J, Accola K, Levy P, Duncan D, Yanagawa B, Ely J, Graeve A; PROACT Investigators. Anticoagulation and Antiplatelet Strategies After On-X Mechanical Aortic Valve Replacement. J Am Coll Cardiol. 2018 Jun 19;71(24):2717-2726. doi: 10.1016/j.jacc.2018.03.535.</citation>
    <PMID>29903344</PMID>
  </reference>
  <reference>
    <citation>Tossios P, Reber D, Oustria M, Holland-Letz T, Germing A, Buchwald D, Laczkovics A. Single-center experience with the On-X prosthetic heart valve between 1996 and 2005. J Heart Valve Dis. 2007 Sep;16(5):551-7.</citation>
    <PMID>17944128</PMID>
  </reference>
  <reference>
    <citation>Williams MA, van Riet S. The On-X heart valve: mid-term results in a poorly anticoagulated population. J Heart Valve Dis. 2006 Jan;15(1):80-6.</citation>
    <PMID>16480016</PMID>
  </reference>
  <reference>
    <citation>Wu Y, Butchart EG, Borer JS, Yoganathan A, Grunkemeier GL. Clinical evaluation of new heart valve prostheses: update of objective performance criteria. Ann Thorac Surg. 2014 Nov;98(5):1865-74. doi: 10.1016/j.athoracsur.2014.05.006. Epub 2014 Sep 23. Review.</citation>
    <PMID>25258160</PMID>
  </reference>
  <reference>
    <citation>Jawitz OK, Wang TY, Lopes RD, Chavez A, Boyer B, Kim H, Anstrom KJ, Becker RC, Blackstone E, Ruel M, Thourani VH, Puskas JD, Gerdisch MW, Johnston D, Capps S, Alexander JH, Svensson LG. Rationale and design of PROACT Xa: A randomized, multicenter, open-label, clinical trial to evaluate the efficacy and safety of apixaban versus warfarin in patients with a mechanical On-X Aortic Heart Valve. Am Heart J. 2020 Sep;227:91-99. doi: 10.1016/j.ahj.2020.06.014. Epub 2020 Jun 25.</citation>
    <PMID>32693197</PMID>
  </reference>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 9, 2019</study_first_submitted>
  <study_first_submitted_qc>October 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 29, 2019</study_first_posted>
  <last_update_submitted>November 3, 2021</last_update_submitted>
  <last_update_submitted_qc>November 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aortic Valve Stenosis</mesh_term>
    <mesh_term>Aortic Valve Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Warfarin</mesh_term>
    <mesh_term>Apixaban</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

